Expression of human clotting factor IX with EBV shuttle vector
摘要
Culture of patient somatic cells, transfected with therapeutic genes into genomic DNA with retroviral vectors, followed by colony selection, amplification, and reimplantation of transformed cells into patient, has been Widely used for clinical trial of gene therapy in the past years. But the disadvantages of this protocol are obvious. (i) To a great extent the expression level of the transfected cells depends on the different integration sites,which cause the various expression rates from different colonies; besides, the life span of
引用本文(GB/T 7714)
王洪伟, 郑冰, 薛京伦, 等. Expression of human clotting factor IX with EBV shuttle vector[J]. 中国科学通报:英文版, 1995.
引文网络
本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。